An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines

The global scientific community has been successful in their efforts to develop, test, and commercialize vaccines for COVID-19. However, the limited supply of these vaccines remains to be a widespread problem as different nations have started their respective vaccine rollouts. Policymakers continue...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Charlle L. Sy, Kathleen B. Aviso, John Frederick D. Tapia, Ador R. Torneo, Anthony S.F. Chiu, Raymond R. Tan
Formato: article
Lenguaje:EN
Publicado: AIDIC Servizi S.r.l. 2021
Materias:
Acceso en línea:https://doaj.org/article/32044bf87ef8401a8d0fc97fc40ca529
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32044bf87ef8401a8d0fc97fc40ca529
record_format dspace
spelling oai:doaj.org-article:32044bf87ef8401a8d0fc97fc40ca5292021-11-15T21:49:05ZAn Operations Research-Based Approach to the Allocation of COVID-19 Vaccines10.3303/CET21880132283-9216https://doaj.org/article/32044bf87ef8401a8d0fc97fc40ca5292021-11-01T00:00:00Zhttps://www.cetjournal.it/index.php/cet/article/view/11806https://doaj.org/toc/2283-9216The global scientific community has been successful in their efforts to develop, test, and commercialize vaccines for COVID-19. However, the limited supply of these vaccines remains to be a widespread problem as different nations have started their respective vaccine rollouts. Policymakers continue to deal with the difficult task of determining how to allocate them. This research work will present how the use of mathematical models can provide valuable decision support under such conditions. Both a linear programming model and a nonlinear programming model have been developed to determine the optimal allocation of COVID-19 vaccines that minimize fatalities and COVID-19 transmission, respectively. These scenarios have to be dealt with when not enough vaccines are available, and the pandemic is still in progress. The model is capable of handling large scale allocation problems such as those intended for the general population of a country. It could also be scaled down for organizations such as private companies or universities. The model also considers multiple vaccines with different levels of efficacy. The distribution of vaccines reduces transmission and relative infectiousness of individuals across different age groups. A hypothetical case study is solved to illustrate the computational capability of the models. The results indicate that priority should be given to the elderly when fatalities are minimized. In contrast, the younger population should then be prioritized when the objective shifts to suppressing contagion.Charlle L. SyKathleen B. AvisoJohn Frederick D. TapiaAdor R. TorneoAnthony S.F. ChiuRaymond R. TanAIDIC Servizi S.r.l.articleChemical engineeringTP155-156Computer engineering. Computer hardwareTK7885-7895ENChemical Engineering Transactions, Vol 88 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chemical engineering
TP155-156
Computer engineering. Computer hardware
TK7885-7895
spellingShingle Chemical engineering
TP155-156
Computer engineering. Computer hardware
TK7885-7895
Charlle L. Sy
Kathleen B. Aviso
John Frederick D. Tapia
Ador R. Torneo
Anthony S.F. Chiu
Raymond R. Tan
An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
description The global scientific community has been successful in their efforts to develop, test, and commercialize vaccines for COVID-19. However, the limited supply of these vaccines remains to be a widespread problem as different nations have started their respective vaccine rollouts. Policymakers continue to deal with the difficult task of determining how to allocate them. This research work will present how the use of mathematical models can provide valuable decision support under such conditions. Both a linear programming model and a nonlinear programming model have been developed to determine the optimal allocation of COVID-19 vaccines that minimize fatalities and COVID-19 transmission, respectively. These scenarios have to be dealt with when not enough vaccines are available, and the pandemic is still in progress. The model is capable of handling large scale allocation problems such as those intended for the general population of a country. It could also be scaled down for organizations such as private companies or universities. The model also considers multiple vaccines with different levels of efficacy. The distribution of vaccines reduces transmission and relative infectiousness of individuals across different age groups. A hypothetical case study is solved to illustrate the computational capability of the models. The results indicate that priority should be given to the elderly when fatalities are minimized. In contrast, the younger population should then be prioritized when the objective shifts to suppressing contagion.
format article
author Charlle L. Sy
Kathleen B. Aviso
John Frederick D. Tapia
Ador R. Torneo
Anthony S.F. Chiu
Raymond R. Tan
author_facet Charlle L. Sy
Kathleen B. Aviso
John Frederick D. Tapia
Ador R. Torneo
Anthony S.F. Chiu
Raymond R. Tan
author_sort Charlle L. Sy
title An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
title_short An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
title_full An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
title_fullStr An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
title_full_unstemmed An Operations Research-Based Approach to the Allocation of COVID-19 Vaccines
title_sort operations research-based approach to the allocation of covid-19 vaccines
publisher AIDIC Servizi S.r.l.
publishDate 2021
url https://doaj.org/article/32044bf87ef8401a8d0fc97fc40ca529
work_keys_str_mv AT charllelsy anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT kathleenbaviso anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT johnfrederickdtapia anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT adorrtorneo anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT anthonysfchiu anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT raymondrtan anoperationsresearchbasedapproachtotheallocationofcovid19vaccines
AT charllelsy operationsresearchbasedapproachtotheallocationofcovid19vaccines
AT kathleenbaviso operationsresearchbasedapproachtotheallocationofcovid19vaccines
AT johnfrederickdtapia operationsresearchbasedapproachtotheallocationofcovid19vaccines
AT adorrtorneo operationsresearchbasedapproachtotheallocationofcovid19vaccines
AT anthonysfchiu operationsresearchbasedapproachtotheallocationofcovid19vaccines
AT raymondrtan operationsresearchbasedapproachtotheallocationofcovid19vaccines
_version_ 1718426775163240448